E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 3, 2026
March 4, 2026
cb7da201-2ee5-4140-a2ea-b6dc8e2108b1
Related Documents
M14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-interventional Studies That Utilize Real-World Data for Safety Assessment of Medicines
Guidance DocumentMarch 3, 2026Center for Drug Evaluation and Research
Postapproval Pregnancy Safety Studies: Guidance for Industry
Guidance DocumentMay 8, 2026Center for Drug Evaluation and Research
Questions and Answers on Biosimilar Development and the BPCI Act: Guidance for Industry
Guidance DocumentMarch 9, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.